Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis

Renal impairment is a major concern in patients taking high-dose methotrexate (MTX) for malignancy, but it has not been fully explored in rheumatoid arthritis (RA) patients taking low-dose MTX. This study aimed to elucidate the dose-dependent effects of MTX on the renal function of patients with RA....

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Hayashi, Keigo, Sada, Ken-Ei, Asano, Yosuke, Asano, Sumie Hiramatsu, Yamamura, Yuriko, Ohashi, Keiji, Morishita, Michiko, Watanabe, Haruki, Narazaki, Mariko, Matsumoto, Yoshinori, Wada, Jun
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7599222/
https://ncbi.nlm.nih.gov/pubmed/33127957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-75655-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky